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The 34-kDa periplasmic iron-transport protein (FBP)
from Neisseria gonorrhoeae (nFBP) contains Fe(III) and
(hydrogen)phosphate (synergistic anion). It has a char-
acteristic ligand-to-metal charge-transfer absorption
band at 481 nm. Phosphate can be displaced by (bi)car-
bonate to give FeCO3nFBP (max 459 nm). The local
structures of native Fe-PO4-nFBP and FeCO3nFBP
were determined by EXAFS at the FeK edge using full
multiple scattering analysis. The EXAFS analysis re-
veals that both phosphate and carbonate ligands bind to
FBP in monodentate mode in contrast to transferrins,
which bind carbonate in bidentate mode. The EXAFS
analysis also suggests an alternative to the crystallo-
graphically determined position of the Glu ligand, and
this in turn suggests that an H-bonding network may
help to stabilize monodentate binding of the synergistic
anion. The anions oxalate, pyrophosphate, and nitrilo-
triacetate also appear to serve as synergistic anions but
not sulfate or perchlorate. The oxidation of Fe(II) in the
presence of nFBP led to a weak Fe(III)nFBP complex
(max 471 nm). Iron and phosphate can be removed from
FBP at low pH (pH 4.5) in the presence of a large excess
of citrate. Apo-FBP is less soluble and less stable than
FenFBP and binds relatively weakly to Ga(III) and
Bi(III) but not to Co(III) ions, all of which bind strongly
to apo-human serum transferrin.
Iron is an essential nutrient absolutely required for all or-
ganisms with the possible exception of Lactobacillus and Bor-
relia burgdorferi (1, 2). Iron is abundant in the environment
but tends to precipitate as ferric hydroxide under aerobic aque-
ous conditions at neutral pH where the concentration of free
Fe(III) is 1018 M, 12 orders of magnitude lower than that
required for bacterial growth (3, 4). In humans and other mam-
mals, iron is sequestered and transported by transferrins and
lactoferrins and stored in ferritin (5). The tight binding of iron
by these proteins leads to a very low level of free iron in the
host, which acts as an antibacterial defense mechanism. How-
ever, some pathogenic bacteria, such as Neisseria meningitidis,
N. gonorrhoeae, Haemophilus influenzae, Actinobacillus acti-
nomycetemcomitans, and Pasteurella hemolytica, have devel-
oped highly efficient iron-uptake systems including specific
iron-binding proteins (FBPs)1 to sequester iron from hosts (6,
7). Iron is transported in the periplasm of these pathogens by
FBP, which is a highly conserved periplasmic protein required
for virulence (7–12). Therefore, structural studies of FBP are
important for understanding the iron-uptake mechanism in
these pathogens and could aid the design of novel bacteriostatic
agents targeted on this protein.
FBP has been called “bacterial transferrin” because of its
remarkable similarity to transferrin. A recent crystal structure
of FBP from H. influenzae (hFBP) has revealed that it is struc-
turally homologous to one lobe of transferrin but without se-
quence homology (9). The Fe(III) binding site in hFBP resem-
bles the two Fe(III) binding sites in transferrin containing two
cis-Tyr ligands and one His ligand but with Glu instead of the
Asp residue found in transferrins (see Structure I). A striking
difference is that hFBP appears to have a monodentate tetra-
hedral phosphate (or hydrogen phosphate) bound to Fe(III) as
the synergistic anion together with a water ligand (9), whereas
transferrins use bidentate (bi)carbonate as the synergistic an-
ion. Transferrin can use other carboxylates as synergistic an-
ions but cannot use phosphate or sulfate (13). The synergistic
anion binding properties of transferrins including their role in
metal binding and release have been well documented (14–16),
but only recently have the synergistic anion binding properties
of bacterial FBP been investigated (9, 17). The FBP from N.
gonorrhoeae (nFBP) has been biochemically characterized (18)
and subsequently expressed in Escherichia coli (19, 20). It has
been reported that a large excess of NaHCO3 increases the iron
binding capacity of apo-FBP (21).
We have investigated the binding of anions and metal ions to
recombinant FBP from N. gonorrhoeae by a variety of tech-
niques including UV-visible spectroscopy, inductively coupled
plasma atomic emission spectrometry (ICP-AES), electrospray
mass spectrometry, multinuclear NMR spectroscopy, and EX-
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AFS. EXAFS is a technique capable of providing, in principle,
metal-ligand bond lengths to the same accuracy as a small
molecule crystal structure (0.02 Å). In the case of metallopro-
teins, this accuracy significantly exceeds the accuracy obtained
from all but atomic resolution (1.2 Å) crystal structures.
However, this accuracy has not been routinely achieved be-
cause of limitations in theory and difficulty with the required
calculations. Also, there is a limit to which similar bond lengths
can be resolved, which is dependent on the data range and is
typically of the order of 0.1 Å. Significant improvements in
EXAFS data analysis have occurred in recent years including
the use of constrained and restrained refinement (22–25), map-
ping techniques (25, 26), use of three-dimensional crystal struc-
ture coordinates (27–29), and full (i.e. including interligand as
well as intraligand) multiple scattering (30, 31). These methods
have been combined in the analysis program EXCURV98 (32)
and have recently been applied to the copper protein azurin
(33) where it gave rise to a significant improvement in the
quality of the final simulation and model. We apply these
methods here to both the (H)PO4 and (H)CO3 adducts of
FenFBP. These studies are important for understanding the
mechanisms for iron transport in this pathogenic bacterium.
EXPERIMENTAL PROCEDURES
Materials—Electrophoresis was carried out using a Bio-Rad Protean
II Minigel system (protein) and Invitrogen H5 system (DNA). An Am-
ersham Biosciences fast protein liquid chromatography system and
columns were used for chromatographic separations of proteins. Pre-
cast SDS-PAGE gels (10% bis-Tris) were purchased from Novex and
were used according to the manufacturer’s instructions.
Monosodium citrate (Aldrich), NaHCO3 (Aldrich), nitrilotriacetic
acid (H3NTA, Aldrich), NaH2PO4, and Na2HPO4 (BDH), tetrasodium
pyrophosphate (Strem), Hepes (Aldrich), Tris (Aldrich), cetyltrimethyl-
ammonium bromide (CTAB, Aldrich), and NaH13CO3 (MSD isotopes,
99% enriched) were used as received. Iron, phosphorus, gallium, bis-
muth, and cobalt atomic absorption standard solutions were purchased
from Aldrich. All other chemicals were reagent grade. A freshly pre-
pared physiological buffer was used with final concentrations of 4 mM
NaH2PO4, 100 mM NaCl, and 25 mM NaHCO3 (pH 7.4).
Stock solutions of [Fe(III)(NTA)2], [Ga(III)(NTA)2], and [Bi(III)
(NTA)] were prepared from the iron, gallium, and bismuth atomic
absorption standard solutions and the stoichiometric amount of
H3NTA. The pH values were raised slowly to 5.5 with microliter
amounts of NaOH (1 M). Diluted solutions were used where necessary.
Aqua Co(III) ions are unstable under normal conditions, and so
Na3Co(III)(CO3)3 was prepared according to published procedures (34,
35). The purity was confirmed by carbon and cobalt analysis. A stock
solution of Na3Co(III)(CO3)3 was prepared in 1 M NaHCO3 according to
published methods (36). This complex has been used successfully to load
human transferrin with Co(III) (36).
Overexpression of nFBP—nFBP was overexpressed in E. coli Top10
One ShotTM or DH5F cells (Invitrogen) transformed with pTRC99A/
FBP. A single colony from freshly transformed cells was used to inoc-
ulate 5 ml of 2YT broth (Bacto-tryptone (16 g), Bacto-yeast extract (10
g), NaCl (5 g) dissolved in distilled water (1 liter), and then adjusted to
pH 7.5 with NaOH) containing 100 g/ml ampicillin in a sterile 10-ml
vial. This culture was shaken overnight at 310 K and used to inoculate
1 liter of 2YT with 100 g/ml ampicillin in sterile 500-ml flasks. After
the flask was shaken overnight at 310 K, a pink pellet of cells was
isolated by centrifugation at 10,000  g for 15 min at 277 K and stored
at 253 K.
Purification of nFBP—nFBP was purified by a modification of the
method of Berish et al. (20). The pink pellet (5 g) was defrosted at
room temperature and resuspended in 50 ml of 1 M Tris (pH 8.0). 50 ml
of 2% CTAB then was added followed by stirring slowly overnight at 310
K. The white insoluble material was removed by centrifugation at
10,000  g for 15 min at 277 K. The supernatant (cell-free extract) was
diluted to a final volume of 1 liter by adding distilled water and then
filtered using Whatman number 4 paper (Fisher). The cell-free extract
was applied to a RESOURCE®S cation exchange column (1 or 6 ml,
Amersham Biosciences) connected to a fast protein liquid chromatog-
raphy system, washed according to the manufacturer’s instructions,
and equilibrated with 10 mM Tris buffer (pH 8.0). The filtered CTAB
extract was loaded onto the column at a flow rate of 4 ml/min. Unbound
proteins were removed by extensive washing with low salt buffer.
Proteins were eluted with a linear NaCl gradient of low-to-high salt
(0–1 M NaCl) over 20 column volumes in 10 mM Tris buffer. Pink
fractions were collected and were analyzed by SDS-PAGE. nFBP was
desalted by dialysis and concentrated by ultrafiltration (Amicon con-
centrator). The concentration of purified protein was determined by the
BCA method using bovine serum albumin as a reference (37).
Preparation of Apo-nFBP—Apo-nFBP was prepared by treatment of
holo-nFBP solutions in a Centricon 10 microconcentrator (Amicon) with
250 mM sodium citrate (pH 4.5) at least four times until there was
negligible absorbance at 481 nm. The apo-nFBP was then washed four
times with 2 ml of 0.1 M KCl. At this point, the colorless protein was
exhaustively exchanged into the buffer to be used in different experi-
ments (Centricon 10).
Mass Spectrometry—Electrospray mass spectrometry was performed
on a Micromass Platform II quadrupole mass spectrometer equipped
with an electrospray ion source. The purified holo-protein or apoprotein
samples in 10 mM Hepes (pH 7.2) were diluted with MeOH/H2O (1:1,
v/v) to a final concentration of 20 M (20 pmol/l), and CH3COOH (final
concentration 0.5%) was added to the samples before measurement.
The final pH of the protein samples was 3.7. The mass spectrometer
was scanned at intervals of 0.1 s, the scans were accumulated, the
spectra were combined, and average molecular mass was determined
using the MaxEnt and Transform algorithms of massLynx software.
UV-visible Spectroscopy—All of the UV experiments were performed
with 1-cm cuvettes on a computer-controlled Shimadzu UV-1000 spec-
trometer with temperature control at 298 or 310 K. UV-difference
spectra after the addition of metal complex to apo-FBP were recorded
immediately and at different time intervals. For titration experiments,
aliquots of metal complex (0.5–10 l) were added and the solution was
left to equilibrate at 298 K for 30 min. The binding or release of Fe(III)
was monitored by the increase or decrease in absorbance at 481 nm.
NMR Spectroscopy—FBP samples were dissolved in 0.1 M KCl in 10%
D2O, 90% H2O. The pH was adjusted to 7.4  0.1 when necessary using
NaOH and HCl (0.1 M). The pH* values (meter readings) of NMR
solutions were recorded before and after NMR measurements.
1H NMR spectra were recorded on a Bruker DMX 500 spectrometer
at 500 MHz, using 0.6 ml of FBP solution (1 mM) in 5-mm tubes at 298
K using 1,000 transients, 6-s (50o) pulses, 1.8-s recycle time, 16,384
data points, and water suppression via presaturation. The chemical
shift reference for 1H was sodium trimethylsilyl-d4-propionate (TSP).
Resolution enhancement of the spectra was achieved by processing the
free induction decays with a combination of unshifted sine-bell and
exponential functions (line broadening of 1.5–20 Hz) on a Silicon Graph-
ics computer using XWIN-NMR software.
Proton-decoupled 31P NMR spectra were recorded on a Bruker DMX
500 spectrometer operating at 202 MHz. Typically, 3,000–10,000 tran-
sients were collected using a pulse-width of 6 s (50o), relaxation delay
of 2 s, and 16,384 data points. The 31P reference was external 85%
H3PO4. The spectra were processed using exponential functions (line
broadening of 2–10 Hz).
Two-dimensional [1H,1H], NOESY (mixing time of 100 ms), and
TOCSY spectra (mixing time of 50 ms) (38, 39) were acquired on a
Bruker DMX 500 spectrometer at 298 K using 4,096 data points in the
f2 dimension [1H], 32–64 increments of t1, acquisition time of 0.2 s, 96
scans, and 512 increments in the f1 dimension in a total time of 21 h.
Qsine functions were used in both dimensions for processing data using
XWIN-NMR 2.0 software. The residual water signal was suppressed by
presaturation or pulsed-field gradients. Peaks were referenced to TSP.
ICP-AES—ICP-AES was performed on a Thermo Jarrell Ash IRIS
STRUCTURE 1. Fe(III) binding site in FBP. The state of protonation
of phosphate is unknown.
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spectrometer using standard methods. Metal-loaded proteins and apo-
proteins were purified by using Centricon 10 (Amicon) ultrafilters and
washing three times with ultrapure water followed by ultrafiltration
after each washing. The final protein solution was diluted with Tris
buffer (10 mM).
pH Measurements—The pH values of the solutions were adjusted
with HCl or NaOH (DCl or NaOD for samples in D2O solution) and
determined using a Corning 240 pH meter equipped with an Aldrich
microcombination electrode calibrated with Aldrich buffer solutions at
pH 4, 7, and 10. The pH meter readings for D2O solutions are recorded
as pH* values, i.e. uncorrected for the effect of deuterium.
X-ray Absorption Spectroscopy—X-ray spectra were recorded at the
iron K edge on EXAFS station 9.3 at Daresbury Laboratory Synchro-
tron Radiation Source (operating at 2 GeV) using a Si220 double
crystal monochromator and vertically focusing mirror for harmonic
rejection. Data for native nFBP and apo-nFBP loaded with Fe(III) in the
presence of bicarbonate rather than phosphate were collected at 13 K
(using a liquid helium cryostat) in fluorescence mode using a 13-ele-
ment solid state germanium detector. Data were collected in k space
using a k3-weighted regime for counting time with a total scan time of
40 min. 28 scans were collected from each sample. The edge positions
were calibrated against an Fe foil. Samples were prepared as follows.
Purified native nFBP was concentrated to 7 mM by ultrafiltration and
washed three times with 0.1 M KCl. FeCO3nFBP (2 mM) was prepared
by reacting apo-nFBP with 1.2 mol eq of Fe(NTA)2 in Hepes buffer (pH
7.4) in the presence of 10 mM sodium bicarbonate. The excess of
Fe(NTA)2 and free NTA was removed from the yellowish-pink solution
by ultrafiltration washing four times with 0.1 M KCl. Data were pro-
cessed using EXCALIB and SPLINE (modified for use with EXCURV)
(40). The EXAFS data were converted into k space. The photoelectron
wave vector k is related to the incident photon energy (E) and to the
threshold energy (Eo) by Equation 1,
k   2mE  Eo	
2 (Eq. 1)
where m is the mass of an electron. The EXAFS data were analyzed
using the fast curved wave (or Rehr-Albers) theory (41) including up to
third order multiple scattering contributions in EXCURV98 (32). This
version of the program includes interligand scattering terms in the
calculations (31). Phase shifts were calculated using Hedin-Lundquist
exchange and correlation potentials (42, 43) and tested against the
EXAFS data for iron-protoporphyrin IX chloride (chlorohemin) (44) and
Fe-EHPG (45). All data analysis was carried out on raw EXAFS data
(without Fourier filtering) weighted by k3 to compensate for diminish-
ing amplitude at high k.
The EXAFS analysis proceeded in a number of stages. (i) Single
scattering analysis of the first shell (ligand or nearest neighbor) atoms
was the first stage. The Fe-PO4-nFBP data were then analyzed as
follows. (ii) Constrained (rigid body) EXAFS was fit using the crystal-
lographic coordinates of hFBP (1.6 Å resolution, PDB code 1MRP) as
starting model. The EXAFS data were simulated retaining the three-
dimensional coordinates with full (i.e. including interligand in addition
to intraligand) multiple scattering. Protein residues were truncated,
keeping only those atoms within 5 Å of central iron atom that should be
relatively well ordered with respect to iron such as all atoms of the
phenolate rings of Tyr-195 and Tyr-196 (n  2  7), all atoms of the
imidazole ring of His-9 (n  5), all atoms of the phosphate group (n 
5), the terminal part of Glu-57 (n  4) (CG, CD, OE1, OE2), and water
(n  1). This gave a total of 29 atoms. Treating each residue as a rigid
body means that the position of all the atoms in a multi-atom ligand can
be defined using only three parameters: one distance (usually the li-
gand atom) and two polar angles ( and ) while simultaneously main-
taining the overdeterminancy of the refinement (see Table III) and
maintaining the internal geometry of the residue. (iii) One parameter
(Fermi energy) was refined, and Debye-Waller factors were set at val-
ues from final simulation. (iv) 13 parameters were refined: Fermi en-
ergy, 6 distances for ligand atoms, 5 angles for non-water residues, one
single Debye-Waller factor for the 6 six-liganding (nearest neighbor)
atoms. It was assumed that the Debye-Waller factors increased with
distance from the central atom as it is physically unrealistic to allow
more distant non-liganding atoms to have stronger thermal correlations
with the metal atom than the nearer atoms (23, 25, 46). Debye-Waller
factors were grouped together for similar distances and atom type and
scaled to the refined Debye-Waller factor for the ligand atoms. (v) 14
parameters were refined as described above plus a rotation around the
vector defined by CG-CD of Glu-57. The starting parameters for the
rotation around the CG-CD vector were established by mapping this
parameter against the related positional parameters for the Glu-57
ligand. The validity of this methodology was tested using the Fe-EHPG
data (see “Results”). (vi) Similar ligand distances (  0.1 Å) were
grouped, giving three rather than six ligand distances, and the refine-
ment was repeated. (vii) Restrained refinement against “ideal” bond
lengths was derived from the Engh and Huber library (47). A total of 55
two-dimensional 1–2, 1–3, and 1–4 bond length restraints within resi-
dues were applied (23). These restraints together with not refining 
values are sufficient to maintain the planarity of the phenolate and
imidazole rings. A weighting of EXAFS:restraints of 0.5:0.5 was used.
Further details of the procedure used were described previously (for
details see Refs. 23, 33, and 46).
Uncertainties were estimated in two ways; 1) by varying a parameter
away from its optimal value while optimizing all other parameters until
(D	)2 (as defined in Equation 1 of Ref. 48) increased by 1 above its
minimum value (48) and 2) by calculation of the co-variance matrix. The
statistical component of the noise was quantified by subtracting a
smooth function obtained from a low pass Fourier filter from the back-
ground-subtracted data.
Once a satisfactory simulation of the EXAFS data for Fe-PO4-nFBP
had been obtained, PO4 was replaced with CO3 (giving 28 shells), and
the analysis was repeated with the FeCO3nFBP data. After completion
of most of the EXAFS analysis, the crystal structure coordinates of
nFBP (PDB code 1D9Y) at moderate (2.2 Å) resolution became available
(www.rcsb.org).2 They have been included in the comparisons.
RESULTS
Overexpression and Characterization of nFBP
Cloning and Overexpression of nfbp in E. coli—The vector
pTRC99A/FBP was used for the overexpression of the nfbp
gene. Wild-type nFBP was overexpressed in both Top10 and
DH5F E. coli cell lines transformed with pTRc99A/FBP. The
formation of a pink pellet was indicative of the overexpression
of nFBP. Expression levels were similar in 2YT for both cell
lines, but Top10 cells containing pTRC99A/FBP gave deeper
pink pellets and were used for large scale protein expression.
Optimal yields of protein were obtained by aerobic cell growth
in 2YT at 310 K for 28–30 h. From a 1-liter cell culture,
100–200 mg of purified protein was normally obtained.
Purification of nFBP—The overexpressed protein was lo-
cated in the periplasm of E. coli, because nFBP contains an
N-terminal signal sequence that directs FBP to the periplasmic
space (20). The cationic detergent CTAB was used to prepare a
periplasmic extract. The method of Berish et al. (20) (4% CTAB
extraction for 1 h at 310 K) still gave a pink pellet after
centrifugation. This suggested that the extraction was not com-
plete. After using 2% CTAB with extraction overnight, a white
pellet with red supernatant was obtained after centrifugation,
indicating that a complete extraction had been achieved.
The diluted cell-free extract was applied to a cation exchange
column that was then eluted with a 1 M NaCl gradient. Pink
fractions were eluted at 0.16 M salt and were collected. After
dialysis and ultrafiltration, pink-colored high purity nFBP was
obtained as shown by the SDS-PAGE gel, which had one major
band at 34 kDa (see supplemental Fig. S1 under “Supporting
Information”). These profiles are similar to the FBP purified
from gonococci by Mietzner et al. (18). Crystallization trials
were successful and confirmed the high purity of the protein.
Characterization of nFBP—The molecular masses of both
holo-nFBP and apo-nFBP were investigated by electrospray
mass spectrometry. When the pink holo-nFBP solution was
added into the mass spectrometry buffer containing 50% or-
ganic solvent (CH3CN or CH3OH), a red precipitate formed
that dissolved after gentle shaking, giving rise to a colorless
solution. However, no precipitate formed with the apo-nFBP
sample. Holo-FBP had an apparent molecular mass of 33,643
Da (see supplemental Fig. S2 under “Supporting Information”),
2 D. E. McRee, C. M. Bruns, P. A. Williams, T. A. Mietzner, and R.
Nunn, unpublished data.
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in agreement with the amino acid sequence (309 amino acids
without iron or phosphate; theoretical mass of 33,639.39 Da).
Apo-nFBP itself had an apparent molecular mass of 33,648 Da.
This finding suggests that under the conditions of mass spec-
trometry neither holo-nFBP nor apo-nFBP had iron or syner-
gistic anion bound to the protein and that the nFBP signal
sequence had been cleaved at Asp-23 upon translocation to the
periplasm.
The iron and phosphorus contents of both holo-nFBP and
apo-nFBP were determined by ICP-AES. The protein concen-
trations (holo-nFBP, 5.83 mg/ml; apo-nFBP, 5.64 mg/ml) were
measured by the BCA method using bovine serum albumin as
a standard (37) and were converted into molar concentrations
(holo-nFBP, 1.72  104 M; apo-nFBP, 1.67  104 M) according
to their calculated molecular masses. The samples were diluted
10 times for ICP-AES analysis, and three repeat measure-
ments were made. The iron and phosphorus contents of the
proteins are listed in Table I. These data suggest that the “as
purified” holo-nFBP contains 1 mol iron and 1 mol phosphorus
(as the synergistic anion phosphate)/mol protein, whereas apo-
nFBP contains neither iron nor phosphorus.
UV-visible Studies—UV-visible spectra of holo-FBP and apo-
FBP are shown in Fig. 1. Both holo-nFBP and apo-nFBP ex-
hibit a band with a maximum intensity at 279 nm and a
shoulder near 290 nm, indicative of the presence of Trp resi-
dues. The molar extinction coefficients at 280 nm (
280) were
determined as 44,200 M1cm1 for apo-nFBP and 48,900
M1cm1 for holo-nFBP. Apo-nFBP has no band in the visible
region, whereas holo-nFBP exhibits a broad band centered
near 481 nm, which gives rise to the pink color of the protein.
The value of 
481 for holo-nFBP was determined to be 2,440
M1cm1.
NMR Spectroscopic Studies—Holo-nFBP was highly soluble
in 0.1 M KCl (7 mM), and the solution was stable at 277 K as
well as at room temperature. However, apo-nFBP was much
less soluble (2 mM) and less stable at 277 K but more stable at
room temperature. Precipitates formed in apo-nFBP solutions
a few days after preparation, even at 0.2 mM.
31P NMR investigations revealed no 31P signal for either
apo-nFBP or holo-nFBP. This was expected for apo-nFBP, be-
cause ICP-AES studies revealed no phosphorus associated with
the apoprotein. However, ICP-AES detected one phosphorus in
the holo-protein, so the absence of a 31P NMR signal suggests
that this phosphorus atom must be close to the paramagnetic
Fe(III) center, which broadens the 31P signal beyond detection.
High spin 3d6 Fe(III) is known to be an effective NMR-broad-
ening agent. The effects can arise from both through-space
(dipolar broadening and  1/r6) and through-bond (contract
interaction, delocalization of unpaired electrons) interactions
(49).
1H NMR spectra for both holo-nFBP and apo-nFBP are
shown in supplemental Fig. S3 under “Supporting Informa-
tion.” Major 1H NMR differences exist between the apo-protein
and the holo-forms. For example, sharp peaks at   7.78 (a),
  7.73 (b), and   7.24 (c) for apo-nFBP (as shown in
supplemental Fig. S3) have disappeared from the spectrum of
holo-nFBP and are probably attributed to aromatic CH protons
from the residues close to Fe(III). The peaks at   0.03 (d),
  0.60 (e), and   0.65 (f) in the high field region are
probably from methyl groups lying below or above side chain
aromatic rings (e.g. Trp) and are shifted by ring current effects.
These peaks are broadened for holo-nFBP, suggesting that they
are near to the Fe(III) or are less mobile in the holo-protein.
The two-dimensional TOCSY and two-dimensional NOESY
spectra of apo-FBP and holo-FBP contain many overlapping
peaks because of the large size of the protein (50). More NOESY
connectivities were seen for apo-nFBP than for holo-nFBP,
especially in the region between 5 and 6.6 ppm (50). All of these
features confirm that recombinant apo-FBP and holo-FBP are
folded proteins. Further analysis of the NMR data is beyond
the scope of this paper.
Anion Binding Properties of nFBP
We investigated whether nFBP from N. gonorrhoeae con-
tains phosphate as a synergistic anion and whether this can be
replaced by carbonate, the normal synergistic anion for trans-
ferrin, or by other anions.
UV-visible Studies—A titration of Fe(III) (as Fe(NTA)2) with
apo-nFBP in the presence of 5 mM phosphate (10 mM Hepes
buffer (pH 7.4)) was monitored by UV-visible spectroscopy. As
shown in Fig. 2A, a new broad band centered at 481 nm ap-
peared immediately and increased in intensity upon the addi-
tion of Fe(III) until 1 mol eq was reached. A plot of A481
against the molar ratio (r) of Fe to apo-FBP is shown in Fig. 2B.
It can be clearly seen that with the increase in r, the band at
481 nm increased in intensity and reached a plateau at r  1,
which suggests that one mol Fe(III) binds strongly per mol
nFBP.
Similar experiments were performed using other anions (py-
rophosphate, (bi)carbonate, oxalate, and NTA) instead of phos-
phate. In all of these cases, Fe(III) bound strongly to nFBP with
a 1:1 molar ratio. A distinctive position of the LMCT
(Tyr3Fe(III)) band was observed as shown in Fig. 3 and Table
II. The wavelength of the LMCT band of transferrin is known
to be sensitive to the nature of the anion including the substi-
tution of carbonate by glyoxylate or glycine (51, 52). This find-
ing suggests that both carboxylates and phosphates can act as
synergistic anions for nFBP. The wavelength of the LMCT
band in the presence of phosphate is the same as the band for
the native protein (481 nm), suggesting that phosphate is the
native synergistic anion. A titration performed in physiological
buffer (100 mM NaCl, 4 mM phosphate, and 25 mM bicarbonate
(pH 7.4)) gave rise to a LMCT band at 481 nm, which suggests
that phosphate is the bound anion under these conditions.
Phosphate binding was also confirmed by the anion exchange
studies described below.
A titration of Fe(NTA)2 as the Fe(III) source with apo-nFBP
in 0.1 M KCl but in the absence of any added synergistic anion
gave rise to a specific band at 457 nm. This implies that NTA
can also act as a synergistic anion. NTA is known to be able to
act as a synergistic anion in transferrins (51, 52), confirmed by
TABLE I
Iron and phosphorus analysis of holo-nFBP and apo-nFBP
Protein Fe/protein molar ratio P/protein molar ratio
Holo-nFBP 1.04  0.06 0.98  0.1
Apo-nFBP not detected 0.05  0.02
FIG. 1. UV-visible spectra of holo-nFBP and apo-nFBP (33 M)
in 0.1 M KCl (pH 7.4).
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the recent 2.1 Å resolution x-ray crystal structure of an Fe(III)-
ovotransferrin-NTA ternary complex (53). The wavelength of
the LMCT band of Fe(III)-NTA-hTF (465 nm) is the same as
that for Fe(III)CO3-hTF (52). Therefore, it is reasonable that
max for the LMCT band of Fe(III)-NTA-nFBP is similar to that
for Fe(III)CO3nFBP (459 nm).
Because Fe(III) can be loaded into hTF by the addition of
Fe(II) to air-saturated solutions of the apo-protein (54), we
titrated apo-nFBP with Fe(II) ammonium sulfate in the ab-
sence of other added anions. The oxidation of Fe(II) to Fe(III)
appeared to be accelerated by the presence of nFBP and led to
a weak FenFBP complex with a max of 472 nm. The saturation
of nFBP was complete after the addition of 3 mol eq of Fe(II)
(as judged by the ratio A470/A400). Because this is not the
wavelength of the FeCO3nFBP complex, we conclude that
ambient bicarbonate (0.14 mM (pH 7.4), 298 K (55)) is not able
to promote the formation of an Fe(III)CO3nFBP complex. The
identity of the bound anion(s) in FenFBP formed via Fe(II)
oxidation is unknown but could be hydroxide, and it is possible
that such a complex is unstable via the loss of iron as ferric
hydroxide. The experiments described below appear to rule out
sulfate as a bound anion.
Titrations of Fe(NTA)2 with apo-nFBP were performed in the
presence of sulfate or perchlorate to see whether they can serve
as synergistic anions. LMCT bands centered at 458 nm were
observed but were ascribed to bound NTA (
458 2,800
M1cm1) as the synergistic anion. Moreover, phosphate ex-
change studies on Fe-PO4-nFBP monitored by
31P NMR (de-
scribed below) also do not support sulfate or perchlorate as a
synergistic anion for FenFBP.
Synergistic Anion Exchange
UV-visible Studies—FeCO3nFBP was prepared by mixing
1.0 mol eq of Fe(NTA)2 with apo-nFBP (83 M) in the presence
of a large excess of HCO3
 (5 mM). The broad band at 459 nm
was indicative of the formation of the FeCO3FBP. Upon the
addition of phosphate (final concentration of 5 mM) to this
solution, the LMCT band shifted to 481 nm over a period of 30
min (see Fig. 4). This finding suggested that bound carbonate is
readily displaced by phosphate. Similar experiments were also
performed with Fe-oxalate-nFBP (oxalate as synergistic an-
ion). When phosphate (final concentration of 5 mM) was added
to the Fe-oxalate-nFBP, the LMCT band decreased in intensity
and shifted from 451 to 481 nm over a period of 30 min,
suggesting that the synergistic anion oxalate was displaced by
phosphate.
UV-visible studies were also performed to see whether phos-
phate in native nFBP can be displaced by carbonate. As shown
in Fig. 5A, when a 200-fold molar excess of NaHCO3 was added
to native nFBP solution (0.11 mM, 0.1 M KCl (pH 8.0)), the
LMCT band of native FBP gradually shifted from 481 to 460
nm and increased in intensity over a period of 5 h. This finding
suggests that phosphate in nFBP has been displaced and that
FeCO3nFBP has formed.
Similar experiments were also performed using a 400-fold
molar excess of sulfate or perchlorate instead of bicarbonate;
however, no shifts of the LMCT band of the native nFBP were
observed.
31P NMR Studies—To confirm that the synergistic anion
(hydrogen) phosphate can be displaced by (bi)carbonate, 31P
NMR studies were carried out. When a 50-fold molar excess of
NaHCO3 (pH 8.0) was added to a solution of native holo-nFBP (1
mM (pH 8.0), 0.1 M KCl), no 31P NMR peak appeared after incu-
bation for 12 h at 298 K, which suggests that phosphate binds
strongly to FenFBP. However, when a 200-fold molar excess of
NaHCO3 was added, a new
31P NMR peak appeared at 3.23 ppm
and grew to its maximum intensity 24 h later (see Fig. 5B). This
peak has a chemical shift characteristic of free phosphate (56,
57). This confirms that phosphate is the native synergistic anion
in nFBP and that it can be displaced by a large excess of carbon-
ate. To confirm that phosphate was displaced, the sample was
ultrafiltered. A colorless filtrate was obtained, which gave a 31P
NMR peak at 3.23 ppm (i.e. free phosphate).
In contrast, after the addition of a 400-fold molar excess of
Na2SO4 or NaClO4 to solutions of holo-nFBP and incubation for
FIG. 2. Titration of apo-nFBP with
Fe(III). A, UV-visible spectra of apo-
nFBP (84 M) and after addition of
[Fe(NTA)2] (0, 0.2, 0.4, 0.6, 0.8, 1.0, 2.0
mol eq) in 10 mM Hepes, 5 mM NaH2PO4
(pH 7.3), 298 K. B, titration curve for
binding of Fe(III) to apo-nFBP based on
the intensity of the LMCT band of Fe-
PO4-nFBP at 481 nm (conditions as
above).
FIG. 3. UV-visible spectra of FenFBP in the presence of differ-
ent synergistic anions. Conditions: 1.0 mol eq of [Fe(NTA)2] was
added to 33–84 M apo-nFBP in 10 mM Hepes buffer (pH 7.3), 5 mM
anion, 298 K. Anions are pyrophosphate (1), oxalate (2), carbonate (3),
NTA (4), and phosphate (5).
TABLE II
Characteristics of the ligand-to-metal charge transfer band of
Fe-nFBP in the presence of various synergistic anionsa
Aniona
Phosphate Pyrophosphate Carbonate Oxalate NTA
max (nm) 481 439 459 451 457
 (M1 cm1) 2440 1650 2750 3050 2780
a Conditions: 1–2 mol eq Fe(NTA)2 was added to apo-nFBP (33–84
M) in the presence of 5 mM anion, 10 mM Hepes, pH 7.3, at 298 K.
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3d at 298 K, no 31P NMR peak appeared. This together with the
UV studies suggests that neither sulfate nor perchlorate can
act as a synergistic anion for FenFBP.
EXAFS Comparison of Phosphate-FenFBP and
Carbonate-FenFBP
FeK-edge EXAFS studies were carried out to investigate the
local structural differences between FePO4nFBP and
FeCO3nFBP. The edge structure (XANES) and edge positions
were the same for FePO4nFBP and FeCO3nFBP, and their
positions are consistent with the expected 3 oxidation state
for Fe. However, the spectra differ markedly in other respects
(see Fig. 6). The amplitude of the EXAFS oscillations for
FePO4nFBP dies away with increasing k, whereas the ampli-
tude for the FeCO3nFBP EXAFS is relatively even throughout
its range. This results in significant differences in the corre-
sponding Fourier transforms, which are not the result of the
different EXAFS data ranges available for the calculation of
the Fourier transforms (see supplemental Fig. S4 under “Sup-
porting Information”). The Fourier transform for FePO4nFBP
shows two overlapping peaks of similar intensity, whereas that
for FeCO3nFBP is dominated by a single peak with a shoulder
on the longer distance side. The two overlapping peaks for
FePO4nFBP can be simulated with two oxygen backscatterers
at an average distance of 1.94 Å and four oxygen/nitrogen
backscatterers at an average distance of 2.12 Å. The fit is
slightly improved if the nitrogen is allowed to refine to a sep-
arate (2.24 Å) distance. The EXAFS for FeCO3nFBP refines to
four donor ligands at an average distance of 1.98 Å and two
ligands at 2.20 Å (the shoulder in the Fourier transform). These
peaks are the result of scattering from the atoms directly
coordinated to Fe(III). The first shell peak in the Fourier trans-
form is considerably more intense for the carbonate adduct
than the phosphate adduct. This is reflected in the correspond-
ing Debye-Waller factors (22  0.001 and 0.004, respectively).
This is not an artifact of data collection. Both data sets were
collected at the same temperature, and the total count rate on
the fluorescence detector was kept approximately the same for
both samples (half of the maximum linear count rate). This
finding suggests that the ligands are significantly more ordered
with respect to the metal with CO3 bound compared with PO4.
Despite the difference between the spectra, both data sets have
a peak in their respective Fourier transforms at 2.6 Å for which
the crystal structures have no obvious candidate atoms. The
FePO4nFBP data also have a peak at 3.2 Å, which is at the
correct distance for the phosphorus of the synergistic phosphate
ligand. Although these data together with the significant differ-
ence in the first shell appear to confirm that the two nFBP
samples have different synergistic anions, it must be remem-
bered that in addition to small “rigid” ligands such as phosphate
and carbonate, the atoms of the Tyr and His ligands contribute
significant multiple scattering in the 3–6 Å range. Because the
ligand bond lengths are different between the two samples, the
Tyr and His multiple scattering patterns will also differ. Thus, it
is the different distribution of ligand bond lengths and pattern of
peaks in the 3–6 Å range that supports the notion of different
synergistic anions. To confirm this finding, the constrained and
restrained full multiple scattering analyses in three-dimensional
space were carried out using all the well ordered atoms of the
ligand residues within 5 Å of the central atom.
Multiple Scattering EXAFS Analysis
EXAFS simulations of the FePO4FBP data using the hFBP
and nFBP crystallographic coordinates gave very poor results
(R-factors of 60.9% and 73.4%, respectively) (see supplemental
Fig. S5). Given the difference in the estimated errors between
the two techniques (0.1–0.2 Å for the crystal structures;
0.02 Å for EXAFS), this is not particularly surprising. A
comparison of the two sets of crystallographic coordinates (see
Table IV) reveals significant disagreement in the Fe-ligand
bond lengths. The nFBP structure gives both Fe-Tyr bond
lengths as similar (1.84 and 1.88 Å), whereas the hFBP struc-
ture suggests a large split (0.14 Å) with one very short Fe-
tyrosine bond (1.78 Å). The two structures also differ by 0.21 Å
in the Fe-OH2 bond length. The FePO4nFBP EXAFS data do
not support the short Fe-Tyr distance of the hFBP crystal
structure. With the hFBP coordinates, the R-factor can be
reduced from 61 to 42% by changing the Fe-Tyr-195 bond
length from 1.78 to 1.9 Å, which is similar to the Fe-Tyr-196
distance and more typical of iron-tyrosinate systems. On (con-
strained) refinement of the Fe-ligand bond lengths (using ei-
ther coordinates), the Fe-OH2 distance refines to 2.10 Å,
slightly longer than the 2.02 Å of the hFBP crystal structure
but still significantly shorter (by 0.13 Å) than the distance
suggested by the nFBP crystal structure. For the constrained
refinement, a total of 13 parameters were initially varied: the
Fermi energy, 6 Fe-ligand bond lengths, 5 Fe-ligand angles,
and the Debye-Waller factor for ligand-bonded (first shell) at-
oms. At this stage, the best fit obtainable had an R-factor of
30.5% and did not adequately simulate the peak at 2.6 Å in the
Fourier transform or the EXAFS data between 7 and 9 Å1.
Because the 2.6 Å peak is also present in the FeCO3nFBP
data, it was concluded that it was not likely to be attributable
to the synergistic phosphate anion. There is no independent
evidence to suggest an additional unidentified ligand at this
distance. To check whether the assignment of the ligands to the
six refined distances were correct, the ligands were systemat-
ically swapped to the other five distances, and the refinement
was repeated. This finding revealed a number of false minima
with R-factors of 33–35%, but none improved upon the fit to the
2.6 Å peak. Therefore, it was necessary to consider what more
significant changes from the crystal structure might be respon-
sible for this difference. The simulation of the “outer” multiple
scattering peaks (3–5 Å) was good. 3–5 Å peaks result largely
from the multiple scattering from the Tyr and His rings. There-
fore, attempts to model the 2.6 Å peak by decreasing the Fe-
ligand angles for the Tyr and His rings all resulted in signifi-
cantly worse fits. Attempts were made to model a “bidentate”
phosphate by (a) removing the water and rotating the phos-
phate group to place the oxygen closest to the water at this
position and (b) rotating the phosphate group to place an oxy-
gen in the 2.6 Å Fourier transform peak. In both cases, this
resulted in high R-factors and very poor fits to the EXAFS,
FIG. 4. Displacement of carbonate from FeCO3nFBP by phos-
phate. UV-visible spectra showing the shift of the LMCT band at
various times after adding 5 mM NaH2PO4 to 83 M FeCO3FBP in 10
mM Hepes, 50 mM KCl, 5 mM NaHCO3 (pH 7.3) at 298 K. 1, FeCO3FBP;
2, 1 min; 3, 10 min; 4, 20 min; 5, 30 min; and 6, 1 h after the addition
of 5 mM NaH2PO4. The shift of the LMCT band from 460 to 481 nm is
indicative of displacement of the synergistic anion carbonate by
phosphate.
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partly because of the easily identified P-atom being at the
wrong distance. Clearly, as a “single atom” ligand, the OH2
cannot make any contribution to the 2.6 Å peak. This left
Glu-57 as the only possible ligand that could account for the
scattering at 2.6 Å. Additionally, unlike the other ligands, the
side chain of glutamate has significant rotational freedom. The
EXAFS-refined and starting models were examined using the
molecular modeling program XFIT (part of the XtalView pack-
age) (58). This examination suggested that a rotation of the
terminal portion of the side chain of Glu-57 could place atoms
at the correct distances to account for the unfilled 2.6 Å peak in
the Fourier transform. This rotation could be achieved in two
ways. (i) The same rotamer is maintained, but the terminal
position is rotated around the CG–CD bond (this maintains the
residue at approximately the same position with respect to the
other ligands). (ii) Select the rotamer (using the XFIT in-built
rotamer library) that most closely gives the desired bond dis-
tances to the iron. For method (i), a series of multidimensional
maps of the position of these atoms (still treating the ligand as
a rigid body) against EXAFS Fit Index were calculated. They
strongly supported the notion that such a rotation together
with a small translation (to maintain the correct first shell
bond length for Glu) would lead to a satisfactory fit to the
EXAFS data. This change in the position of Glu-57 immediately
led to a significant reduction in the R-factor from 30 to under 26%
and good fits to both the EXAFS and Fourier transforms. A
further reduction in the R-factor (to 23.9%) was then obtained by
refining the position of Glu-57 together with the original param-
eters for the other five ligands, giving the constrained fit in Table
III. The deviation of the CG-CD vector in this model from its
initial position arose during the final constrained refinement of
all 14 parameters as the Fe-OE1-Glu angle was refined.
The model derived above was obtained by a left-handed
rotation around the CG-CD vector as orientated in Fig. 7. This
places the Fe-bonded oxygen (OE1) closer to the phosphate
ligand and the longer oxygen (OE2) closer to His-9. Equally
valid is the opposite rotation placing Fe-bonded OE1 closer to
His-9 and the longer OE2 closer to the phosphate. On con-
strained refinement, such a model gives an acceptable R-factor
of 24.8%. Constrained refinement using the alternative rota-
mer model (as described in (ii) above) also gave an acceptable
fit but with a slightly higher R-factor (25.2%). Because it gave
the best fit, only the model derived by a left-hand rotation of
Glu-57 around the CG-CD vector was analyzed further.
Restrained refinement against ideal bond lengths (47) led to
a further reduction in the R-factor (from 23.9 to 20.5%) without
any significant changes to the model (see Tables III and IV and
Fig. 7). The restrained refinement was well determined with a
parameter/observation ratio of 2.0.
It was necessary to keep the six ligand distances separate
until the final stages of the refinement to accommodate the
changes in Fe-ligand distances from the initial model. This also
allowed for the comparison with the crystallographic distances.
An examination of the EXAFS-derived distances for the Fe-
PO4-FBP data shows these distances as falling into three dis-
tinct groups: 1) Tyr-195 and Glu-57 (1.93 and 1.95 Å, distance
correlation 0.8), 2) Tyr-196, water, and phosphate (2.08, 2.10,
and 2.13 Å, distance correlation 0.7–0.8), and 3) His-9 (2.28 Å).
The distance correlations among these three groups were low
(0.05–0.2). Therefore, the effects on both the constrained and
restrained models of allowing only three Fe-ligand distances
were examined. This resulted in marginally higher final fit
indices and R-factors with distances as expected at average
values with respect to the six-distance refinement (see Tables
III and IV). In the restrained refinement, some of the effect of
this averaging is accommodated by a small increase in the
deviation from ideal geometry. Relaxing the bond length re-
straints resulted in unrealistic and unacceptable deviations
from the known internal geometry of the ligands. Also, it did
not lead to the simulation of the 2.6 Å peak.
The nFBP crystal coordinates suggest a similar distance for
the two tyrosine ligands, whereas the EXAFS data for Fe-PO4-
FBP suggest a large split (0.15–0.17 Å). This split is similar to
FIG. 5. Displacement of phosphate
from FePO4nFBP by carbonate. A,
UV-visible spectra of FePO4nFBP (0.11
mM) and 0.5, 2.5, 3.5, and 5.5 h after the
addition of 20 mM NaHCO3 at 298 K in 0.1
M KCl (pH 8.0). The shift of the LMCT
band from 481 to 460 nm is indicative of
the slow substitution of the synergistic
anion phosphate by carbonate. B, 31P
NMR spectrum of holo-nFBP (1 mM in 0.1
M KCl (pH 8.0), 298 K) before and after
the addition of a 200-fold molar excess of
NaHCO3 at various times. The appear-
ance of the peak at 3.23 ppm (character-
istic of free phosphate) after the addition
of NaHCO3 is indicative of displacement
of the synergistic anion phosphate by car-
bonate. For holo-nFBP, the 31P resonance
is broadened beyond detection by the
paramagnetic effects of Fe(III).
FIG. 6. Comparison of the final restrained EXAFS fit for Fe-
FBP with phosphate and carbonate as bound anions. EXAFS
spectra (top) and Fourier transforms (bottom) of FePO4nFBP (A) and
FeCO3nFBP (B) are shown. Solid line, experimental; dotted line, cal-
culated. The k ranges used for the calculating the Fourier transforms
were 13.1 and 11.1 Å 1 for FePO4nFBP and FeCO3nFBP, respec-
tively. A comparison of the Fourier transforms calculated using the
same k range can be seen in supplemental Fig. S4 under “Supporting
Information.”
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that in the hFBP coordinates, but both tyrosines are displaced
to longer distance by 0.15 Å. Attempts to model the similar
Fe-tyrosine distances of the nFBP coordinates in the Fe-PO4-
FBP EXAFS data (using both the original and EXAFS-derived
rotation of Glu-57 with Tyr-196 and Glu-57 distances swapped)
resulted in very poor fits and high R-factors, even after exten-
sive refinement.
Fe-EHPG has been widely used as a model for transferrins
(59, 60), because it contains 2 amino, 2 phenoxy, and 2 carboxyl
groups in a single hexadentate binding site. It is also a useful
model for FBPs. EXAFS data for Fe-EHPG were used to test
the validity of the method used to fit the Glu residue in the FBP
EXAFS data. Starting with the crystal structure (45), the phe-
nyl rings and carboxyl groups were individually tilted away
from their initial (correct) positions by up to 60°. The rest of the
structure then was refined against the EXAFS data using
multiple scattering and restrained refinement,3 and finally, the
maps of the “tilt angle” against other refined parameters were
calculated. The back atoms of the phenyl rings were too far
from the central atom (4.7–5.6 Å) for small angular tilts (30°)
to have any significant effect on the fit. However, the carboxyl
group with its carbon at 2.85 Å is a better analogy to the Glu
residue in the FBP structure. This proved much more sensitive
to angle in all cases, finding the original angular position of the
carboxyl group to within 5–10°. This finding supports the case
that with this type of multiple ring-containing site, the use of
multiple scattering with constraints/restraints does allow the
orientation of a carboxyl (or similar) ligand to be determined
with confidence.
For the FeCO3nFBP EXAFS data, the PO4 of the model was
replaced with an idealized CO3, placing the bonding oxygens of
the two ligands at the same positions and the carbon of CO3
along the phosphate (Fe)O–P axis. The carbonate was rotated
around the (Fe)O–C axis, and a clear minimum was found. By
analogy with the Fe-PO4-FBP EXAFS, attempts to model a
bidentate CO3 resulted in high R-factors and poor fits to the
EXAFS. The situation and solution with Glu-57 were identical
to the Fe-PO4-nFBP case. Also analogous with the Fe-PO4-FBP
data were the correlations for the six separate Fe-ligand dis-
tances. The groups found were Tyr-195/Tyr-196 (both 1.96 Å),
3 Distance-based constrained refinement with distance refinement is
not appropriate for the EHPG ligand as the constraints will also pre-
vent any metal-ligand distance changes.
FIG. 7. The Fe binding site in Fe-
FBP. A comparison of the EXAFS model
for FePO4nFBP (blue) with the crystal
structure of Fe- PO4-hFBP (red) (A) and
the EXAFS model for FePO4nFBP (blue)
with the EXAFS model for FeCO3nFBP
(red) (B) is shown.
TABLE III
Statistics for different EXAFS models for FePO4nFBP and FeCO3nFBP
FePO4nFBP FeCO3nFBP
k Range (Å1) 13.1 11.1
Crystal structure fit hFBP nFBP
Ni/pa 33 33
Fit indexb 17.3 27.2
R-factor (%)c 60.9 73.4
Constrained fit
Before rotation of Glu57 6 distances 3 distancesd 6 distances 3 distancese
Ni/pa 2.5 — — —
Fit indexb 5.14 — — —
R-factor (%)c 30.5 — — —
After rotation of Glu57
Ni/pa 2.4 2.4 1.9 1.9
Fit indexb 3.56 4.03 6.02 6.12
R-factor (%)c 23.9 25.7 26.6 26.9
Restrained fit
Ni/pa 2.0 2.0 2.0 2.0
Fit indexb 0.59 0.61 1.35 1.42
R-factor (%)c 20.5 20.9 24.4 25.5
Deviation from Engh and
Huber distances (%)
1.05 1.18 0.92 1.00
f 45 45 41 41
(	)2 [(	)
2]g 52 [1.16] 55 [1.22] 48 [1.17] 51 [1.24]
a Ni is the number of independent data points; p is the number of refined parameters (including those that were refined at previous stages of
the analysis).
b Fit index   i(1/i
2){k3[	exp(ki)  	
th(ki)]}
2 where   jk
3	exp(kj) and 	exp and 	th are the experimental and theoretical EXAFS, respectively.
c R-factor  i
N(1/i)k
3	exp(ki)  	th(ki)  100%.
d Because of correlation, ligands were grouped into three distances: Glu57/Tyr195, Tyr196/PO4/H2O, and His
9.
e Because of correlation, ligands were grouped into three distances: Tyr195/Tyr196, Glu57/H2O, and His
9/CO3.
f  is the number of degrees of freedom,   Ni  p.
g (	)2 is as defined in Ref. 48 and should be  . (	)2 should 3 1.
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Glu-57/H2O (2.00 Å, 2.06 Å, respectively) and CO3/His-9 (2.19
Å, 2.21 Å, respectively). The correlations in the six-distance
refinements suggest that it is safer to model both EXAFS data
sets using only three Fe-ligand distances (see Tables III and
IV).
An absolute index of the goodness of fit, which takes into
account the degree of overdeterminancy of the EXAFS fit, is
given by the reduced 	2 function (	)
2. For an acceptable fit,
(	)2 should be approximately equal to , the number of degrees
of freedom, and therefore, (	)
2 should tend to 1. Values for ,
(	)2 and (	)
2 for the final fits are given in Table III. As the
values of (‚	)2 are approximately equal to , the fits are ac-
ceptable on a statistical basis, and statistical rather than sys-
tematic errors dominate (as may be expected for this type of
data). This finding suggests that the uncertainties given in
Table IV adequately represent the uncertainties of the best-fit
parameter values. These uncertainties were calculated by
varying a parameter away from its optimal value while opti-
mizing all other parameters until (‚	)2 increased by 1 above its
minimum value (48). Uncertainties calculated by this method
were compared with values obtained using a co-variance ma-
trix. These two methods should be equivalent and after round-
ing gave the same estimates for the uncertainties.
Examination of the resulting models for both phosphate and
carbonate anions (Fig. 7) suggests a possible reason why nFBP
has the synergistic anion bound in a monodendate mode. In its
suggested new position, OE1 of Glu-57 is well placed to form a
strong hydrogen bond (2.1 Å, O–H–O angle 113°) to the Fe-
bound water at 2.07–2.1 Å. Additionally, Glu-57 may form
hydrogen bonds to PO4 and CO3 synergistic anions if they are
protonated. This potential hydrogen-bonding network remains
intact with both of the other methods discussed for positioning
Glu-57. The hydrogen bond lengths and angles vary but are
within the normal range. Thus, there appears to be a structural
reason why nFBP, unlike transferrin, binds anions in a mono-
dentate mode. The glutamate side chain carboxylate group of
nFBP is part of a hydrogen-bonding network, which both locks
in the Fe-bound water and stabilizes the synergistic anion in a
monodentate configuration.
Metal Binding to nFBP—Transferrin can bind strongly to
metal ions such as Ga(III), Co(III), and Bi(III) in its specific
iron sites (63). Therefore, investigations were made to deter-
mine whether these metal ions can also bind to nFBP. Metal
ion binding to the phenolate groups of the two tyrosine residues
in the specific iron sites of apo-TF leads to two new absorption
bands near 241 and 295 nm because of the perturbations of the
-* transitions of the aromatic rings (61). This effect has been
used to monitor specific metal binding to transferrins by UV-
visible difference spectroscopy (13), and therefore was used
here to investigate the binding of Ga(III), Bi(III), and Co(III) to
apo-nFBP.
Ga(III) Binding—The addition of Ga(NTA)2 to apo-nFBP in
10 mM Hepes (pH 7.3) solution containing 5 mM phosphate at
298 K resulted in two new absorption bands near 245 and 298
nm in the UV difference spectrum. The spectra are character-
istic of metal-tyrosyl coordination and are similar to those
reported for Ga-transferrin complexes (55, 61), suggesting that
Ga(III) binds to the specific iron site in apo-nFBP. A series of
typical UV difference spectra is shown in supplemental Fig.
S6A under “Supporting Information.” A plot of A245 as a
function of r, the molar ratio of total Ga(III) to total FBP, is
shown in supplemental Fig. S6B under “Supporting Informa-
tion.” The non-linear increase in A245 for points below r  1
and the continued increase in A245 for points beyond r  1
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so that excess Ga(III) is needed to saturate the site of
apo-nFBP.
The weak binding of Ga(NTA)2 to apo-nFBP may be attrib-
uted to NTA competition (Ga(NTA), log KML  16.20). To test
this possibility, apo-nFBP was titrated with Ga(NO3)3 (1.43
mM, prepared by dilution and adding NaOH to gallium atomic
absorption standard solution to give pH 2.16) under similar
conditions in the absence of any chelating ligands. Ga(III)
binding to the specific iron site in apo-nFBP was observed as
evidenced by the appearance of two new absorption bands near
245 and 295 nm in the UV difference spectrum (see Fig. 8). The
binding was now stronger as evidenced by the more intense
bands at 245 and 298 nm (
245  8,610 M
1cm1 by r  2).
This shows that NTA does compete with apo-FBP for Ga(III)
binding. However, the increase in A245 for points below, r  1
is still non-linear and still continued to increase beyond r  1.
This implies that binding of Ga(III) to apo-nFBP is not strong.
The 
 values are much lower than those for Ga2-transferrin
(
242 34,000 M
1cm1) and Ga2-lactoferrin (
242 30,000
M1cm1) in the absence of chelating agent (55, 62), implying
that the Ga-nFBP binding is weaker than Ga-transferrin or
Ga-lactoferrin binding. Such weak binding in the absence of
any competing ligand is probably related to the hydrolytic
properties of the Ga(III) ion. In aqueous solution near pH 7.4,
the major unchelated gallium species is Ga(OH)4
. and the weak
binding of Ga(III) to apo-FBP may be attributed to the compe-
tition between apo-FBP and OH (Ga(OH)4
, 4OH  10
16.6
(62)) as discussed previously for Ga-transferrin interactions
(55).
Co(III) Binding—Apo-FBP was titrated with [Co(III)
(CO3)3]
3 in 10 mM Hepes buffer (pH 7.4) in the presence of 5
mM carbonate or 5 mM phosphate. However, no new bands
appeared in the UV difference spectra. This suggested that
specific binding of Co(III) to apo-nFBP is very weak under
these conditions or too slow to be observed.
Bi(III) Binding—Titrations of Bi(NTA) with apo-FBP were
performed in 10 mM Hepes (pH 7.3) in the presence of 5 mM
phosphate (see supplemental Fig. S7 under “Supporting Infor-
mation”) or bicarbonate at 298 K. Specific binding was observed
as evidenced by the appearance of two new absorption bands
near 244 and 297 nm in the UV difference spectrum. However,
as for Ga(III), the much smaller increase in intensity of the
bands at 297 and 244 nm (
244 4,060 M
1cm1 by r  1)





1cm1/Bi (63)) suggests that binding
is rather weak.
DISCUSSION
The successful overexpression of nFBP in E. coli and the
subsequent highly efficient purification from a periplasmic ex-
tract by cation exchange column chromatography gave a high
yield of recombinant nFBP (100–200 mg from 1 liter of cell
culture). Electrospray mass spectra showed essentially the
same molecular mass for both holo-nFBP and apo-nFBP
(33,643 and 33,648 Da, respectively), which agrees with the
predicted molecular mass of 33,639 kDa. This confirms that the
nFBP N-terminal signal sequence was recognized, efficiently
processed, and cleaved to give a mature protein of 309 amino
acids. Also the data show that no metal or synergistic anion
was bound to the protein under mass spectrometric conditions,
i.e. low pH (4) in the presence of 50% CH3OH. The release of
metal was also supported by the formation of a pink holo-FBP
precipitate upon the addition of 50% CH3OH, which subse-
quently redissolved with the formation of a colorless solution.
Holo-nFBP is more soluble than apo-nFBP in aqueous solution,
but the opposite is true for solutions containing organic sol-
vents, which suggest that apo-nFBP is more hydrophobic than
holo-nFBP. A comparison of the recently determined crystal
structure of apo-hFBP (64) with that of holo-FBP (9) reveals
that large conformational changes occur upon the removal of
the metal ion from the protein. Similar changes are likely to
occur for nFBP.
The crystal structure of hFBP (9) suggests that Fe coordi-
nates to phosphate. However, the protein purification process
involved washing FBP-containing cells in phosphate-buffered
saline, a process that could result in synergistic anion exchange
in FBP (2). Also, it is difficult to distinguish phosphate from its
isostructural analogue sulfate by x-ray crystallography. In a
recent 31P NMR study of FBP (17), FBP-containing cells were
again washed with phosphate, and holo-FBP was reconstituted
from apo-FBP in the presence of 50 mM phosphate. Also, it was
surprising that phosphate bound to paramagnetic Fe(III) gave
rise to a resolvable 31P NMR peak. In transferrin, the 13C
resonances of bound (13C) carbonate are broadened beyond
detection (65). In our holo-FBP sample, the 31P resonance of
Fe-bound phosphate also broadened beyond detection. Our
data provide unambiguous compelling evidence that phosphate
is the synergistic anion in recombinant FBP from E. coli. Our
protein purification procedure does not involve any phosphate
contamination, and ICP-AES data gave a 1:1:1 molar ratio of
P/Fe/FBP in holo-FBP and 0:0:1 ratio in apo-FBP. After adding
excess carbonate to holo-FBP solution to displace the bound
phosphate, a 31P NMR resonance for free phosphate was de-
tected (Fig. 5B). These findings indicate that phosphate is
present as an exogenous ligand, the synergistic anion, and are
supported by our UV-visible and EXAFS data.
The pink color of native nFBP or that which develops when
Fe(III) is added to the apo-nFBP solution is attributed to an
intense charge-transfer absorption band at 481 nm. The simi-
larity of the visible spectrum to those of transferrins (13) and
metal-phenolate complexes (66) suggests that they arise from
tyrosine-metal interactions and that the charge-transfer band
must be derived from a ligand phenolate () 3 metal (d*)
transition as in the case of transferrins (67). The molar extinc-
tion coefficient at 481 nm (
481) was determined to be 2440
M1cm1, a value close to that reported by Nowalk et al. (21)
and comparable with half that of Fe2-hTF (
465  4950
M1cm1 (68)). The molar extinction coefficients at 280 nm for
apo-nFBP and holo-nFBP were determined as 
280  44,200 for
apo-nFBP and 
280  48,900 for holo-nFBP, approximately half
of those for apo-hTF and holo-hTF (
280  93,000 M
1cm1 and
103,000 M1cm1, respectively (69)).
The wavelength of maximum absorption is affected by the
FIG. 8. UV difference spectra for Ga(III) binding to apo-FBP.
Ga(NO3)3 (0.2, 0.4, 0.6, 0.8, and 1.0 mol eq) was added to 16.6 M
apo-FBP in 10 mM Hepes, 5 mM NaH2PO4 (pH 7.3), 298 K. The larger
increase in the intensity of the two absorption bands at 245 and 298 nm
compared with Ga(NTA)2 (see supplemental Fig. S5) indicates that
NTA is a strong competitor for Ga(III) binding.
Anion and Metal Binding to nFBP 2499
bound synergistic anion, varying from 450 to 481 nm from
oxalate to phosphate. Different synergistic anions may affect
the energy levels of Fe(III) and cause small changes in the
Fe–O (Tyr) bond lengths (Table IV), leading to differences in
the energy levels between the charge donor (Tyr) and acceptor
(Fe(III)) and contributing to the LMCT bandshifts in UV-visi-
ble spectra. Besides phosphate, other anions such as carbonate,
oxalate, NTA, and pyrophosphate can serve as synergistic an-
ions for Fe(III) in nFBP. The failure of phosphate to act as a
synergistic anion for transferrins is probably because of its
tetrahedral structure that cannot provide the appropriate ge-
ometry for interactions in the specific metal-anion-transferrin
complex, whereas smaller carboxylates can bind to the metal
ion as bidentate anions, leaving no space for the binding of
water (13). This could also contribute to the stronger binding of
iron (compared with nFBP). nFBP can accommodate both phos-
phates and carboxylates as synergistic anions, probably be-
cause the iron-binding cleft in FBP is larger and nearer to the
surface and, therefore, more solvent-accessible. Phosphate can
provide more sites than carbonate for hydrogen bonding with
the protein side chains in the cleft. This may contribute to the
stronger binding compared with carbonate. The state of proto-
nation of bound phosphate or carbonate is unknown. Sulfate
and perchlorate, although isostructural with phosphate, fail to
act as synergistic anions under the conditions we have tried.
This may attributed to their weaker coordination properties
and weaker hydrogen-bonding ability arising from the lower
polarity of Cl–O and S–O bonds compared with P–O and C–O
bonds.
A comparison of the models determined by EXAFS for
FePO4nFBP and FeCO3nFBP shows that a series of minor
changes in Fe-ligand bond lengths and angles together with a
significant difference in overall backscattering intensity (re-
flected in the Debye-Waller factors) are responsible for the
markedly different spectra. Viewed simplistically, Debye-
Waller factors are a measure of the thermal and static disorder
with respect to the Fe(III) atom. As the spectra were collected
at the same low temperature and having ruled out factors
during data collection, this difference is probably because of a
real difference in static disorder. The largest change in distance
on changing the synergistic anion from phosphate to carbonate
is the shortening of the Fe–O(Tyr-196) distance by 0.12 Å. The
shorter distance for the carbonate complex can be directly
equated with its larger extinction coefficient compared with the
phosphate complex. The accuracy of metal-ligand bond lengths
in protein x-ray crystal structures is notoriously difficult to
assess unless diffraction data to atomic resolution (better than
1.2 Å) are available. Global estimates vary for lower resolution
diffraction but range from 0.1 to 0.15 Å for 1.5–2.0 Å diffrac-
tion data to 0.2 Å for 2 Å data (70). The x-ray structure of
hFBP (9) was determined at 1.6 Å and nFBP as 2.2 Å, suggest-
ing that bond length errors may be of the order of 0.1 and 0.2 Å,
respectively. Thus, the differences observed between Fe-ligand
bond lengths in the two crystal structures compared with the
Fe-PO4-nFBP EXAFS are mostly within the estimated errors
for each crystal structure. It should be noted that the differ-
ences observed for three of the bond lengths in the hFBP
(Glu-57, 0.13 Å; Tyr-195, 0.15 Å; Tyr-196, 0.16 Å) and one from
the nFBP structure (Tyr-196, 0.20 Å) are at the top end of the
range. The bond length errors from EXAFS do not have this
same dependence and have been calculated to be in the range
of 0.01–0.04 Å for liganding atoms in this study. Thus, this
analysis is a good illustration of the complementarity of x-ray
diffraction and EXAFS for metalloprotein studies. The crystal
structure provides the metal site topology and (approximate)
metal-ligand bond lengths, whereas EXAFS “fine tunes” these
bond lengths to the equivalent of atomic resolution. As crystal-
lographic data are not available for the CO3 adduct, the EXAFS
data are currently the only structural information on FBPs
with an alternative biologically relevant synergistic anion
bound.
Whereas EXAFS is capable of determining metal-atom dis-
tances with high accuracy, it is not able to measure other
inter-atom distances to anywhere near this level with the ex-
ception of unusual cases (e.g. simple high symmetry systems
with significant multiple scattering). Therefore, it is appropri-
ate to consider the accuracy of the glutamate position and of
the glutamate-water and glutamate-anion hydrogen bond
lengths. The distances of the individual glutamate atoms to Fe
are accurate to the normal level for an EXAFS analysis as
direct Fe-atom distances have been determined. The geometry
of the fragment has been preserved through the use of con-
strained (rigid body) and restrained refinement methods. How-
ever, the absolute position of the fragment with respect to the
other ligands will have significantly greater uncertainty be-
cause assumptions had to be made regarding how to achieve
the rotation. In placing the glutamate residue, it was assumed
that there was no movement of the protein backbone, no change
in any bond lengths within the glutamate, and that movement
could arise only from an allowed rotation (around the CG–CD
bond or CA–CB bond for the alternative rotamer) and a change
in the bond angle between the ligand and the metal. Thus, the
absolute position of the glutamate is chemically reasonable and
is the best fit to the data. Comparisons of the three methods
used to position Glu-57 and the crystallographic coordinates
suggest an uncertainty in the absolute position of the gluta-
mate with respect to the other ligands of approximately 0.7 Å.
Because most of this is attributed to different angular orienta-
tions, the effect on the proposed hydrogen-bonding network is
smaller than this. Hydrogen-bond lengths and angles are
within acceptable values in all three models of the FePO4
nFBP data and also for the FeCO3nFBP data.
The difficulty in fitting the crystallographic coordinates to
the EXAFS data and reliability of both the EXAFS data and fit
have been extensively explored. Reference data collected at the
same time show that the EXAFS data are reliable. Addition-
ally, the 2.6 Å peak is present in two otherwise quite distinct
data sets. The difficulty in fitting the 2.6 Å peak would not have
been observed if only the first shell (using single scattering)
had been fitted. Multiple scattering analysis is not new, but
retaining the three-dimensional coordinates is a more recent
innovation. However, this difficulty would still have been pres-
ent without the three-dimensional information (i.e. if multiple
scattering only within each ligand had been included). A large
number of permutations of the structure was examined, but
none involving the tyrosines, histidine, synergistic anion, or
water ligands fitted the 2.6 Å peak. The use of constraints and
restraints to maintain the internal geometry of the ligands
significantly reduces the number of degrees of freedom of the
model, thereby increasing the likelihood that a unique solution
has been found. An examination of the calculated scattering
pathways for the best EXAFS fit using the crystallographic Glu
orientation (see Table III, Constrained Fit before rotation of
Glu-57) suggests that the absence of calculated scattering at
2.6 Å is not the result of destructive (out of phase) scattering
pathways. Two carbon/nitrogen/oxygen atoms were required to
fit this peak. Although a fit could have been obtained by in-
cluding an additional ligand(s) at this distance, there is no
evidence to support such a model. However, this peak and the
EXAFS data were readily modeled on changing the Glu posi-
tion. The sensitivity of EXAFS data on this type of structure to
the orientation of a carboxylate group is amply demonstrated
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by the FeEHPG complex. The overall similarity of the
FePO4nFBP and FeCO3nFBP EXAFS models and the ease
with which the CO3 data were fitted after rotation of the Glu
residue add credence to the veracity of the model. The changes
to the crystallographic model required for Glu-57 involved an
allowed rotation of a very flexible structure. Therefore, the
EXAFS model is structurally allowed, chemically plausible,
and is by far the best fit to the data. We cannot rule out the
possibility that the difference in the position of the side chain of
Glu-57 suggested by the EXAFS is a consequence of the differ-
ence in the data collection temperature between the EXAFS
and the diffraction data. The EXAFS data were collected at 13
K, the nFBP diffraction data were collected at 100 K, and the
hFBP diffraction data were collected at room temperature. The
collection of protein diffraction data at 100 K has become rou-
tine in recent years, and there is a growing literature on the
differences observed between protein structures at room tem-
perature and at 100 K. Rotations of flexible side chains, espe-
cially of aspartate and glutamate, are fairly common. Collect-
ing protein diffraction data at temperatures close to 13 K is still
uncommon, and there is very little literature comparing ob-
served structural differences at these temperatures. The orien-
tation of the side chain of Glu-57 is the same in both crystal
structures; therefore, the orientation proposed by EXAFS is not
a result of the glass transition. However, we cannot rule out a
structural/phase transition between 100 and 13 K (71). Other
possible reasons for a real structural difference include pH and
the method used to reconstitute the holo-protein. The pH value
appears to be an improbable reason, because the pH of the
EXAFS samples (pH 7.4) is close to that for the hFBP crystal
structure (pH 6.6). A large excess of the synergistic anion was
used when preparing the samples. It is conceivable that such a
large excess displaced the conformational equilibrium away
from the crystallographically observed conformer and toward
the EXAFS-observed conformer. It may be possible that both
the crystallographic and EXAFS-derived Glu orientations
fit the crystallographic electron density maps. Such a scenario
could arise if the electron density was not able to distinguish
between the two orientations at the resolution available or if
the electron density could represent a mixture of the two ori-
entations with only one orientation modeled. Finally, it should
be remembered that EXAFS is not readily able to distinguish
mixtures. That the single orientation derived from EXAFS
could be an average of the crystallographic orientation and
some other undetermined orientation cannot be ruled not.
Because Ga(III), Bi(III), and Co(III) bind strongly to hTF,
which is structurally homologous to nFBP, the weak binding of
these metal ions to nFBP is surprising. There was competition
between NTA and apo-FBP when Ga(NTA)2 was used as a Ga
source. Whether the binding constants are of the same order as
those for metal-hydroxide binding, the binding may be greatly
affected by the hydroxide concentration in the solution, i.e. pH.
Taboy et al. (17) determined an effective binding constant for
Fe(III) binding to nFBP of 2.4  1018 M1 (pH 6.5) (298 K, 0.35
mM phosphate), which is within an order of magnitude of that
for Fe(III) binding to the N-lobe of transferrin in the presence
of carbonate. These differences may be attributed to the much
greater solvent exposure and solvent accessibility of the iron
site in FBP compared with transferrin.
CONCLUSION
We have prepared nFBP in high yield by cloning and over-
expression of nfbp in E. coli. Our ICP-AES and 31P NMR data
suggest that phosphate is the native synergistic anion in re-
combinant nFBP from E. coli. Bound phosphate can be dis-
placed by treating the holo-protein with excess bicarbonate,
and EXAFS studies revealed marked changes in the local struc-
ture of Fe-PO4-FBP compared with FeCO3FBP as a result of
bond length and angle changes together with a significant
difference in local ordering. EXAFS data allowed the refine-
ment of the crystallographically determined metal-ligand bond
lengths and suggested that the water, Glu, and monodentate
synergistic anion are involved in an H-bonding network around
the Fe site. The accurate structure of the Fe/anion site provides
a reliable structural basis for rational design of novel chemo-
therapeutic agents targeted on this key protein, which is re-
quired for virulence and iron uptake in certain pathogenic
bacteria. Oxalate, NTA, and pyrophosphate also appeared to be
capable of serving as synergistic anions but not sulfate or
perchlorate. Apo-FBP is much less stable than the holo-protein
and binds only weakly to Ga(III) and Bi(III), unlike transferrin.
Therefore, attempts to exploit the FBP route for periplasmic
iron transport using heterometal ions, a possible strategy for
the design of novel metalloantibiotics, will need to be based on
other metals.
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15 K has recently been reported for protein crystallographic data (71).
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